Doctor profile · Federal record

Dr. Gerald Ho, M.D.

Rheumatology Physician (CMS: Rheumatology) · Internal Medicine Physician · La Palma, CA

  • NPI 1205833662
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 38 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
5451 la Palma Ave, Suite 25
La Palma, CA 906231730
(714) 670-1340
fax (714) 443-3780
Additional location
2063 S Atlantic Blvd Ste 308
Monterey Park, CA 917546366
(323) 796-0170
fax (323) 796-0220

Credentials & registration

NPPES · NUCC
NPI registered
June 2005 — 21 yrs on file
Profile last updated
December 4, 2024
Year of graduation
1988 — 38 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
California #G67106
Medicaid
CA #00G671060

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1205833662. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
233,428
Distinct HCPCS
10
Medicare allowed
$3,266,077
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 94,925 26 $3
J1602 Injection, golimumab, 1 mg, for intravenous use 26,600 41 $8
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 24,176 42 $18
J0897 Injection, denosumab, 1 mg 18,122 218 $23
J0490 Injection, belimumab, 10 mg 14,738 23 $15
J7332 Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg 13,221 163 $10
J1745 Injection, infliximab, excludes biosimilar, 10 mg 10,410 48 $17
Q5115 Injection, rituximab-abbs, biosimilar, (truxima), 10 mg 4,300 19 $33
J9312 Injection, rituximab, 10 mg 4,000 17 $16
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,846 111 $0

In context: peer comparison

Among 1 peers in this city , average services per provider: 4,168. This provider delivers 56× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,706
Transactions
81
Manufacturers
13
Payer (manufacturer) Industry Txns Amount
Amgen Inc. 31 $477.97
Novartis Pharmaceuticals Corporation 24 $442.75
UCB SA 5 $401.61
ABBVIE INC. 5 $94.66
ANI Pharmaceuticals, Inc. 2 $77.13
PFIZER INC. 7 $51.27
Lilly USA, LLC 1 $34.34
Alexion Pharmaceuticals, Inc. 1 $26.47
Zimmer Biomet Holdings, Inc. 1 $23.61
DePuy Synthes Sales Inc. 1 $23.35
Gilead Sciences, Inc. 1 $20.27
AstraZeneca Pharmaceuticals LP 1 $18.96
E.R. Squibb & Sons, L.L.C. 1 $13.72

By nature of payment

Food and Beverage
$1,445
Travel and Lodging
$261

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
13,255
Patients
4,074
Total drug cost
$3,147,263
Drug Type Claims Patients Total cost
Diclofenac Sodium Generic 2,308 748 $926,431
Hydroxychloroquine Sulfate Generic 1,835 516 $124,181
Prednisone Generic 1,515 399 $15,598
Methotrexate (Methotrexate Sodium) Brand 1,431 391 $64,680
Meloxicam Generic 911 328 $9,762
Sulfasalazine Generic 910 246 $25,169
Gabapentin Generic 731 206 $11,044
Alendronate Sodium Generic 652 215 $10,161
Baclofen Generic 631 249 $13,578
Ibuprofen Generic 527 148 $6,889

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Gerald Ho's medical specialty?
Dr. Gerald Ho practices Rheumatology Physician in La Palma, CA.
Where does Dr. Gerald Ho practice?
Dr. Gerald Ho practices at 5451 la Palma Ave, La Palma, CA 906231730. Office phone: 7146701340.
What is Dr. Gerald Ho's NPI?
Dr. Gerald Ho's National Provider Identifier (NPI) is 1205833662, issued by NPPES.
Does Dr. Gerald Ho accept Medicare assignment?
Yes. Dr. Gerald Ho accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Gerald Ho commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.